The District of Delaware Stops Exela’s Bid To Market Generic Orimev
In the District of Delaware, Judge Leonard Stark recently issued a final judgment and permanent injunction in Cadence Pharms., Inc. v. Exela Pharma. Scis., LLC, No 11-733, 2013 U.S. Dist. LEXIS 166097 (D. Del. Nov. 14, 2013), which prevents defendant Exela Pharmaceutical, Inc. from manufacturing its generic version of OFIRMEV®, an injectable liquid acetaminophen composition. …